Seminars in Nephrology
Volume 29, Issue 3 , Pages 282-299 , May 2009

The Treatment of Hyponatremia

References 

  1. Norenberg MD, Leslie KO, Robertson AS. Association between rise in serum sodium and central pontine myelinolysis. Ann Neurol. 1982;11:128–135
  2. Kleinschmidt-DeMasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science. 1981;211:1068–1070
  3. Laureno R. Central pontine myelinolysis following rapid correction of hyponatremia. Ann Neurol. 1983;13:232–242
  4. Laureno R. Rapid correction of hyponatremia: cause of pontine myelinolysis?. Am J Med. 1981;71:846–847
  5. Laureno R. Experimental pontine and extrapontine myelinolysis. Trans Am Neurol Assoc. 1980;105:354–358
  6. Ashraf N, Locksley R, Arieff AI. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med. 1981;70:1163–1168
  7. Ayus JC, Olivero JJ, Frommer JP. Rapid correction of severe hyponatremia with intravenous hypertonic saline solution. Am J Med. 1982;72:43–48
  8. Sterns RH. The management of symptomatic hyponatremia. Semin Nephrol. 1990;10:503–514
  9. Berl T. Treating hyponatremia: damned if we do and damned if we don't. Kidney Int. 1990;37:1006–1018
  10. Hew-Butler T, Ayus JC, Kipps C, Maughan RJ, Mettler S, Meeuwisse WH, et al. Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007. Clin J Sport Med. 2008;18:111–121
  11. Decaux G, Soupart A. Treatment of symptomatic hyponatremia. Am J Med Sci. 2003;326:25–30
  12. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342:1581–1589
  13. Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. 2007;120(Suppl 1):S1–S21
  14. Achinger SG, Moritz ML, Ayus JC. Dysnatremias: why are patients still dying?. South Med J. 2006;99:353–364
  15. Halperin ML, Kamel KS. A new look at an old problem: therapy of chronic hyponatremia. Nat Clin Pract Nephrol. 2007;3:2–3
  16. Ellison DH, Berl T. Clinical practice (The syndrome of inappropriate antidiuresis). N Engl J Med. 2007;356:2064–2072
  17. Lien YH, Shapiro JI. Hyponatremia: clinical diagnosis and management. Am J Med. 2007;120:653–658
  18. Rowntree LG. Effects on mammals of the administration of excessive quantities of water. J Pharmacol Exp Ther. 1926;29:135–159
  19. Helwig FC, Schutz CB, Curry DE. Water intoxication (Report of a fatal case, with clinical, pathologic and experimental studies). JAMA. 1935;104:1539–1575
  20. Helwig FC, Schutz CB, Kuhn HP. Water intoxication (Moribund patient cured by administration of hypertonic salt solution). JAMA. 1938;110:644–645
  21. Yannet H. Changes in the brain resulting from depletion of extracellular electrolytes. Am J Physiol. 1940;128:683–689
  22. Arieff AI, Llach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore). 1976;55:121–129
  23. Arieff AI. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N Engl J Med. 1986;314:1529–1535
  24. Ayus JC, Wheeler JM, Arieff AI. Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med. 1992;117:891–897
  25. Arieff AI, Ayus JC, Fraser CL. Hyponatraemia and death or permanent brain damage in healthy children. BMJ. 1992;304:1218–1222
  26. Ayus JC, Arieff AI. Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality. JAMA. 1999;281:2299–2304
  27. Arieff AI. Postoperative hyponatraemic encephalopathy following elective surgery in children. Paediatr Anaesth. 1998;8:1–4
  28. Ayus JC, Arieff AI. Pulmonary complications of hyponatremic encephalopathy. noncardiogenic pulmonary edema and hypercapnic respiratory failure. Chest. 1995;107:517–521
  29. Raskind M. Psychosis, polydipsia, and water intoxication (Report of a fatal case). Arch Gen Psychiatry. 1974;30:112–114
  30. O'Brien KK, Montain SJ, Corr WP, Sawka MN, Knapik JJ, Craig SC. Hyponatremia associated with overhydration in U.S. Army trainees. Mil Med. 2001;166:405–410
  31. Gardner JW, Gutmann FD. Fatal water intoxication of an Army trainee during urine drug testing. Mil Med. 2002;167:435–437
  32. Chen X, Huang G. Autopsy case report of a rare acute iatrogenic water intoxication with a review of the literature. Forensic Sci Int. 1995;76:27–34
  33. Tomlinson BE, Pierides AM, Bradley WG. Central pontine myelinolysis (Two cases with associated electrolyte disturbance). QJM. 1976;45:373–386
  34. Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959;81:154–172
  35. Wright DG, Laureno R, Victor M. Pontine and extrapontine myelinolysis. Brain. 1979;102:361–385
  36. Norenberg MD, Papendick RE. Chronicity of hyponatremia as a factor in experimental myelinolysis. Ann Neurol. 1984;15:544–547
  37. Sugimura Y, Murase T, Takefuji S, Hayasaka S, Takagishi Y, Oiso Y, et al. Protective effect of dexamethasone on osmotic-induced demyelination in rats. Exp Neurol. 2005;192:178–183
  38. Brown WD. Osmotic demyelination disorders: central pontine and extrapontine myelinolysis. Curr Opin Neurol. 2000;13:691–697
  39. Karp BI, Laureno R. Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia. Medicine (Baltimore). 1993;72:359–373
  40. Brunner JE, Redmond JM, Haggar AM, Kruger DF, Elias SB. Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study. Ann Neurol. 1990;27:61–66
  41. Sterns RH, Riggs JE, Schochet SS. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med. 1986;314:1535–1542
  42. Verbalis JG, Martinez AJ. Neurological and neuropathological sequelae of correction of chronic hyponatremia. Kidney Int. 1991;39:1274–1282
  43. Rojiani AM, Cho ES, Sharer L, Prineas JW. Electrolyte-induced demyelination in rats (2. Ultrastructural evolution). Acta Neuropathol (Berl). 1994;88:293–299
  44. Rojiani AM, Prineas JW, Cho ES. Electrolyte-induced demyelination in rats (1. Role of the blood-brain barrier and edema). Acta Neuropathol (Berl). 1994;88:287–292
  45. Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol. 1994;4:1522–1530
  46. Tanneau RS, Henry A, Rouhart F, Bourbigot B, Garo B, Mocquard Y, et al. High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients. J Clin Psychiatry. 1994;55:349–354
  47. Ellis SJ. Severe hyponatraemia: complications and treatment. QJM. 1995;88:905–909
  48. Newell KL, Kleinschmidt-DeMasters BK. Central pontine myelinolysis at autopsy; a twelve year retrospective analysis. J Neurol Sci. 1996;142:134–139
  49. Abbasoglu O, Goldstein RM, Vodapally MS, Jennings LW, Levy MF, Husberg BS, et al. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant. 1998;12:263–269
  50. Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 3):iii22–iii28
  51. Abbott R, Silber E, Felber J, Ekpo E. Osmotic demyelination syndrome. BMJ. 2005;331:829–830
  52. Kleinschmidt-Demasters BK, Rojiani AM, Filley CM. Central and extrapontine myelinolysis: then…and now. J Neuropathol Exp Neurol. 2006;65:1–11
  53. Sterns RH, Silver SM. Brain volume regulation in response to hypo-osmolality and its correction. Am J Med. 2006;119(Suppl 1):S12–S16
  54. Thurston JH, Hauhart RE. Brain amino acids decrease in chronic hyponatremia and rapid correction causes brain dehydration: possible clinical significance. Life Sci. 1987;40:2539–2542
  55. Thurston JH, Hauhart RE, Nelson JS. Adaptive decreases in amino acids (taurine in particular), creatine, and electrolytes prevent cerebral edema in chronically hyponatremic mice: rapid correction (experimental model of central pontine myelinolysis) causes dehydration and shrinkage of brain. Metab Brain Dis. 1987;2:223–241
  56. Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia (Implications for the pathogenesis of central pontine myelinolysis). J Clin Invest. 1991;88:303–309
  57. Sterns RH, Baer J, Ebersol S, Thomas D, Lohr JW, Kamm DE. Organic osmolytes in acute hyponatremia. Am J Physiol. 1993;264:F833–F836
  58. Sterns RH, Thomas DJ, Herndon RM. Brain dehydration and neurologic deterioration after rapid correction of hyponatremia. Kidney Int. 1989;35:69–75
  59. Verbalis JG, Gullans SR. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Res. 1991;567:274–282
  60. Verbalis JG, Gullans SR. Rapid correction of hyponatremia produces differential effects on brain osmolyte and electrolyte reaccumulation in rats. Brain Res. 1993;606:19–27
  61. Lien YH. Role of organic osmolytes in myelinolysis (A topographic study in rats after rapid correction of hyponatremia). J Clin Invest. 1995;95:1579–1586
  62. Soupart A, Silver S, Schrooeder B, Sterns R, Decaux G. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. J Am Soc Nephrol. 2002;13:1433–1441
  63. Silver SM, Schroeder BM, Sterns RH, Rojiani AM. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats. J Neuropathol Exp Neurol. 2006;65:37–44
  64. Silver SM, Schroeder BM, Sterns RH. Brain uptake of myoinositol after exogenous administration. J Am Soc Nephrol. 2002;13:1255–1260
  65. Baker EA, Tian Y, Adler S, Verbalis JG. Blood-brain barrier disruption and complement activation in the brain following rapid correction of chronic hyponatremia. Exp Neurol. 2000;165:221–230
  66. Norenberg MD. A hypothesis of osmotic endothelial injury (A pathogenetic mechanism in central pontine myelinolysis). Arch Neurol. 1983;40:66–69
  67. DeLuca GC, Nagy Z, Esiri MM, Davey P. Evidence for a role for apoptosis in central pontine myelinolysis. Acta Neuropathol (Berl). 2002;103:590–598
  68. Ashrafian H, Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness?. Eur J Neurol. 2001;8:103–109
  69. Maallem S, Mutin M, Gonzalez-Gonzalez IM, Zafra F, Tappaz ML. Selective tonicity-induced expression of the neutral amino-acid transporter SNAT2 in oligodendrocytes in rat brain following systemic hypertonicity. Neuroscience. 2008;153:95–107
  70. Maallem S, Mutin M, Kwon HM, Tappaz ML. Differential cellular distribution of tonicity-induced expression of transcription factor TonEBP in the rat brain following prolonged systemic hypertonicity. Neuroscience. 2006;137:51–71
  71. Clifford DB, Gado MH, Levy BK. Osmotic demyelination syndrome (Lack of pathologic and radiologic imaging correlation). Arch Neurol. 1989;46:343–347
  72. Sterns RH. Neurological deterioration following treatment for hyponatremia. Am J Kidney Dis. 1989;13:434–437
  73. Plum F, Posner JB, Hain RF. Delayed neurological deterioration after anoxia. Arch Intern Med. 1962;110:18–25
  74. Thacker AK, Asthana AB, Sarkari NB. Delayed post-anoxic encephalopathy. Postgrad Med J. 1995;71:373–374
  75. Chow KM, Kwan BC, Szeto CC. Clinical studies of thiazide-induced hyponatremia. J Natl Med Assoc. 2004;96:1305–1308
  76. Ayus JC, Achinger SG, Arieff A. Brain cell volume regulation in hyponatremia: role of gender, age, vasopressin and hypoxia. Am J Physiol Renal Physiol. 2008;268:R1143–R1152
  77. Ayus JC, Armstrong D, Arieff AI. Hyponatremia with hypoxia: effects on brain adaptation, perfusion, and histology in rodents. Kidney Int. 2006;69:1319–1325
  78. Vexler ZS, Ayus JC, Roberts TP, Fraser CL, Kucharczyk J, Arieff AI. Hypoxic and ischemic hypoxia exacerbate brain injury associated with metabolic encephalopathy in laboratory animals. J Clin Invest. 1994;93:256–264
  79. Soupart A, Penninckx R, Stenuit A, Decaux G. Lack of major hypoxia and significant brain damage in rats despite dramatic hyponatremic encephalopathy. J Lab Clin Med. 1997;130:226–231
  80. Dubois GD, Arieff AI. Treatment of hyponatremia: the case for rapid correction. In:  Narins RG editors. Controversies in nephrology and hypertension. Philadelphia: Churchill Livingstone; 1984;p. 393–407
  81. Norenberg M. Treatment of hyponatremia: the case for more conservative management. In:  Narins RG editors. Controversies in nephrology and hypertension. New York: Churchill Livingstone; 1984;p. 379–391
  82. Ayus JC, Krothapalli RK, Arieff AI. Changing concepts in treatment of severe symptomatic hyponatremia (Rapid correction and possible relation to central pontine myelinolysis). Am J Med. 1985;78:897–902
  83. Sterns RH. Severe symptomatic hyponatremia: treatment and outcome (A study of 64 cases). Ann Intern Med. 1987;107:656–664
  84. Ayus JC, Krothapalli RK, Arieff AI. Treatment of symptomatic hyponatremia and its relation to brain damage (A prospective study). N Engl J Med. 1987;317:1190–1195
  85. Silver SM, Kozlowski SA, Baer JE, Rogers SJ, Sterns RH. Glycine-induced hyponatremia in the rat: a model of post-prostatectomy syndrome. Kidney Int. 1995;47:262–268
  86. Cluitmans FH, Meinders AE. Management of severe hyponatremia: rapid or slow correction?. Am J Med. 1990;88:161–166
  87. Hantman D, Rossier B, Zohlman R, Schrier R. Rapid correction of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone (An alternative treatment to hypertonic saline). Ann Intern Med. 1973;78:870–875
  88. Cherney DZ, Davids MR, Halperin ML. Acute hyponatraemia and ‘ecstasy’: insights from a quantitative and integrative analysis. QJM. 2002;95:475–483
  89. Steele A, Gowrishankar M, Abrahamson S, Mazer CD, Feldman RD, Halperin ML. Postoperative hyponatremia despite near-isotonic saline infusion: a phenomenon of desalination. Ann Intern Med. 1997;126:20–25
  90. Rae J. Self-induced water intoxication in a schizophrenic patient. Can Med Assoc J. 1976;114:438–439
  91. Snell DM, Bartley C. Osmotic demyelination syndrome following rapid correction of hyponatraemia. Anaesthesia. 2008;63:92–95
  92. Schreiber A, Kubitza S, Luft FC. A woman with postoperative hyponatremia related to desmopressin acetate. Am J Kidney Dis. 2004;44:e3–e6
  93. Goudie AM, Tunstall-Pedoe DS, Kerins M. Altered mental status after a marathon. N Engl J Med. 2005;352:1613–1614
  94. Worthley LI, Thomas PD. Treatment of hyponatraemic seizures with intravenous 29.2% saline. Br Med J (Clin Res Ed). 1986;292:168–170
  95. Drescher T, Klima T, Schifferli J. Seizures, hyponatraemia, and “poison”. Lancet. 2008;371:2144
  96. Speedy DB, Rogers I, Safih S, Foley B. Hyponatremia and seizures in an ultradistance triathlete. J Emerg Med. 2000;18:41–44
  97. Hew-Butler T, Noakes TD, Siegel AJ. Practical management of exercise-associated hyponatremic encephalopathy: the sodium paradox of non-osmotic vasopressin secretion. Clin J Sport Med. 2008;18:350–354
  98. Goudie AM, Tunstall-Pedoe DS, Kerins M, Terris J. Exercise-associated hyponatraemia after a marathon: case series. J R Soc Med. 2006;99:363–367
  99. Hew-Butler T, Anley C, Schwartz P, Noakes T. The treatment of symptomatic hyponatremia with hypertonic saline in an Ironman triathlete. Clin J Sport Med. 2007;17:68–69
  100. Fisher A, Davis M, Croft-Baker J, Purcell P, McLean A. Citalopram-induced severe hyponatraemia with coma and seizure (Case report with literature and spontaneous reports review). Adverse Drug React Toxicol Rev. 2002;21:179–187
  101. Koenig MA, Bryan M, Lewin JL, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70:1023–1029
  102. Bentsen G, Breivik H, Lundar T, Stubhaug A. Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with subarachnoid hemorrhage. Crit Care Med. 2006;34:2912–2917
  103. Tseng MY, Al-Rawi PG, Czosnyka M, Hutchinson PJ, Richards H, Pickard JD, et al. Enhancement of cerebral blood flow using systemic hypertonic saline therapy improves outcome in patients with poor-grade spontaneous subarachnoid hemorrhage. J Neurosurg. 2007;107:274–282
  104. Chuang YC, Chang CS, Hsu SP, Lin TK, Lui CC. Osmotic demyelination syndrome with two-phase movement disorders: case report. Changgeng Yi Xue Za Zhi. 1998;21:526–530
  105. Dellabarca C, Servilla KS, Hart B, Murata GH, Tzamaloukas AH. Osmotic myelinolysis following chronic hyponatremia corrected at an overall rate consistent with current recommendations. Int Urol Nephrol. 2005;37:171–173
  106. Leens C, Mukendi R, Foret F, Hacourt A, Devuyst O, Colin IM. Central and extrapontine myelinolysis in a patient in spite of a careful correction of hyponatremia. Clin Nephrol. 2001;55:248–253
  107. Yu J, Zheng SS, Liang TB, Shen Y, Wang WL, Ke QH. Possible causes of central pontine myelinolysis after liver transplantation. World J Gastroenterol. 2004;10:2540–2543
  108. Pradhan S, Jha R, Singh MN, Gupta S, Phadke RV, Kher V. Central pontine myelinolysis following ‘slow’ correction of hyponatremia. Clin Neurol Neurosurg. 1995;97:340–343
  109. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006;119:71e1-8
  110. Gankam Kengne F, Andres C, Sattar L, Melot C, Decaux G. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM. 2008;101:583–588
  111. Furst H, Hallows KR, Post J, Chen S, Kotzker W, Goldfarb S, et al. The urine/plasma electrolyte ratio: a predictive guide to water restriction. Am J Med Sci. 2000;319:240–244
  112. Edelman IS, Leibman J, O'Meara MW, Birkenfeld LW. Interrelations between serum sodium concentrations, serum osmolality and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest. 1958;37:1236–1256
  113. Nguyen MK, Kurtz I. Role of potassium in hypokalemia-induced hyponatremia: lessons learned from the Edelman equation. Clin Exp Nephrol. 2004;8:98–102
  114. Fichman MP, Vorherr H, Kleeman CR, Telfer N. Diuretic-induced hyponatremia. Ann Intern Med. 1971;75:853–863
  115. Perianayagam A, Sterns RH, Silver SM, Grieff M, Mayo R, Hix J, et al. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin J Am Soc Nephrol. 2008;3:331–336
  116. Mohmand HK, Issa D, Ahmad Z, Cappuccio JD, Kouides RW, Sterns RH. Hypertonic saline for hyponatremia: the risk of inadvertent overcorrection. Clin J Am Soc Nephrol. 2007;2:1110–1117
  117. Liamis G, Kalogirou M, Saugos V, Elisaf M. Therapeutic approach in patients with dysnatraemias. Am J Kidney Dis. 2008;52:144–153
  118. Pham PC, Chen PV, Pham PT. Overcorrection of hyponatremia: where do we go wrong?. Am J Kidney Dis. 2000;36:E12
  119. Oh MS, Uribarri J, Barrido D, Landman E, Choi KC, Carroll HJ. Danger of central pontine myelinolysis in hypotonic dehydration and recommendation for treatment. Am J Med Sci. 1989;298:41–43
  120. Mohmand HK, Issa D, Ahmad Z, Cappuccio JD, Kouides RW, Sterns RH. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Soc Nephrol. 2007;2:1110–1117
  121. Adrogue HJ, Madias NE. Aiding fluid prescription for the dysnatremias. Intensive Care Med. 1997;23:309–316
  122. Soupart A, Penninckx R, Stenuit A, Perier O, Decaux G. Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms. J Neuropathol Exp Neurol. 1996;55:594–601
  123. Soupart A, Ngassa M, Decaux G. Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia. Clin Nephrol. 1999;51:383–386
  124. Oya S, Tsutsumi K, Ueki K, Kirino T. Reinduction of hyponatremia to treat central pontine myelinolysis. Neurology. 2001;57:1931–1932
  125. Croxson M, Lucas J, Bagg W. Diluting delirium. N Z Med J. 2005;118:U1661
  126. Greenberg A, Verbalis JG. Vasopressin receptor antagonists. Kidney Int. 2006;69:2124–2130
  127. Verbalis JG, Zeltser D, Smith N, Barve A, Andoh M. Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolemic hyponatremia: subgroup analysis of a randomized, controlled study. Clin Endocrinol (Oxf). 2008;69:159–168
  128. Schrier R, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355:2099–2112
  129. Udelson JE, Smith WB, Hendrix GH, Painchaud CA, Ghazzi M, Thomas I, et al. Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure. Circulation. 2001;104:2417–2423
  130. Soupart A, Gross P, Legros J-J, Alfodi S, Djillali A, Heshmati H, et al. Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with Satavaptan (SR-121463B), an orally active vasopressin V2receptor antagonist. Clin J Am Soc Nephrol. 2006;1:1154–1160
  131. Zeltser D, Rosansky S, van Rensburg H, Verbalis JG, Smith N. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol. 2007;27:447–457
  132. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355:2099–2112
  133. Verbalis J, Martinez A. Determinants of brain myelinolysis following correction of chronic hyponatremia in rats. In:  Jard S,  Jameson RL editor. Vasopressin. Paris: John Libby; 1991;p. 539–547

PII: S0270-9295(09)00018-7

doi: 10.1016/j.semnephrol.2009.03.002

Seminars in Nephrology
Volume 29, Issue 3 , Pages 282-299 , May 2009

Article Tools

* Image Usage & Resolution